Dr. Violiza Inoa Featured in The Lancet Neurology

We are pleased to announce that Dr. Violiza Inoa has been featured in The Lancet Neurology for her contributions to stroke treatment and education.

About The Lancet Neurology

The Lancet Neurology is the world's leading clinical neurology journal, renowned for its publication of pioneering research that drives change in neurological clinical practice. With an impressive Impact Factor of 48.0, it ranks first among 212 neurology journals globally. The journal covers a wide range of topics, including cerebrovascular disease, Alzheimer's disease, epilepsy, and more, and is a trusted source of knowledge for clinicians, researchers, and policymakers worldwide.

Highlights from the Article

In the feature, Dr. Inoa shares insights into her career achievements, inspirations, and personal reflections. She discusses her passion for serving communities in need, enhancing education, and advocating for minority groups.

Why The Lancet Matters

The Lancet journals are highly influential, with over 36.8 million annual visits and nearly 100 million downloaded articles, ensuring that research published here reaches a global audience.

To learn more about Dr. Inoa's inspiring career and insights, read the full article in The Lancet Neurology here. For additional information about Dr. Inoa, visit her profile on our website here.

Stay connected with Semmes Murphey Clinic for more updates on our exceptional team and their groundbreaking work in neurology.